Viridian Therapeutics, Inc. (VRDN)

30.52 +1.20 (+4.08%) USD  |  NASDAQ  |  Mar 04, 14:46
More

Viridian Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for VRDN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Avantor, Inc. Upgrade
Immunovant, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade